Laszlo Otvos

Commentary: drugs from bugs.

Laszlo Otvos, 2015, Current protein & peptide science.

Design and development of a peptide-based adiponectin receptor agonist for cancer treatment

Ralf Hoffmann, Laszlo Otvos, John Wade, 2011, BMC biotechnology.

The Effect of Selective D- or Nα-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20

John D. Wade, Laszlo Otvos, Frances Separovic, 2017, Front. Chem..

Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.

DuPont Guerry, Francesco M Marincola, Laszlo Otvos, 2006, Cancer research.

Antibacterial peptides and proteins with multiple cellular targets

Laszlo Otvos, L. Otvos, 2005, Journal of peptide science : an official publication of the European Peptide Society.

Monitoring the interference of protein‐protein interactions in vivo by bimolecular fluorescence complementation: the DnaK case

Salvador Ventura, Ralf Hoffmann, Laszlo Otvos, 2008, Proteomics.

The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor

Ralf Hoffmann, Nina Bionda, John D. Wade, 2013, Amino Acids.

Peptide-Based Drug Design

Laszlo Otvos, L. Otvos, 2008, Methods In Molecular Biology™.